iZafe Group AB (OSTO:IZAFE B) FCF Margin % : -120.50% (As of Mar. 2024)

View and export this data going back to 2011. Start your Free Trial

What is iZafe Group AB FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. iZafe Group AB's Free Cash Flow for the three months ended in Mar. 2024 was kr-4.11 Mil. iZafe Group AB's Revenue for the three months ended in Mar. 2024 was kr3.41 Mil. Therefore, iZafe Group AB's FCF Margin % for the quarter that ended in Mar. 2024 was -120.50%.

As of today, iZafe Group AB's current FCF Yield % is -18.08%.

The historical rank and industry rank for iZafe Group AB's FCF Margin % or its related term are showing as below:

OSTO:IZAFE B' s FCF Margin % Range Over the Past 10 Years
Min: -7626.02 Med: -697.75 Max: -136.02
Current: -223.06

During the past 13 years, the highest FCF Margin % of iZafe Group AB was -136.02%. The lowest was -7626.02%. And the median was -697.75%.

OSTO:IZAFE B's FCF Margin % is ranked worse than
83.88% of 825 companies
in the Medical Devices & Instruments industry
Industry Median: -7.06 vs OSTO:IZAFE B: -223.06

iZafe Group AB FCF Margin % Historical Data

The historical data trend for iZafe Group AB's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

iZafe Group AB FCF Margin % Chart

iZafe Group AB Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

FCF Margin %

Get a 7-Day Free Trial

-136.02

-293.63

-7,626.02

-3,308.09

-697.75

iZafe Group AB Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
FCF Margin %	Get a 7-Day Free Trial															-1,843.42	-559.06	-557.42	-286.60	-120.50

Competitive Comparison of iZafe Group AB's FCF Margin %

For the Medical Instruments & Supplies subindustry, iZafe Group AB's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

iZafe Group AB's FCF Margin % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, iZafe Group AB's FCF Margin % distribution charts can be found below:

* The bar in red indicates where iZafe Group AB's FCF Margin % falls into.

iZafe Group AB FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

iZafe Group AB's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	-12.713	/	1.822
	=	-697.75 %

iZafe Group AB's FCF Margin for the quarter that ended in Mar. 2024 is calculated as

FCF Margin	=	Free Cash Flow (Q: Mar. 2024 )	/	Revenue (Q: Mar. 2024 )
	=	-4.109	/	3.41
	=	-120.50 %

iZafe Group AB FCF Margin % Related Terms

Thank you for viewing the detailed overview of iZafe Group AB's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

iZafe Group AB (OSTO:IZAFE B) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » iZafe Group AB (OSTO:IZAFE B) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

Grev Turegatan 11A, Stockholm, SWE, 114 46

Website

https://www.izafe.se

iZafe Group AB is a pure Life-Science company engaged in the development of digital drug dispensing. The company conducts research, development and marketing of digital medical solutions and services for safer drug management at home. iZafe's drug robot Dosell is used to reduce the risk of incorrect medication at home, relieve public care, increase the patient's quality of life and create a safer environment for relatives. The customers consist of public and private care providers in Sweden, the Nordic countries and globally. iZafe sells through well-established partners who already have long and deep customer relationships with the priority customer groups.

iZafe Group AB (OSTO:IZAFE B) Headlines

No Headlines